IssuerAnnouncementDetailsV2Portlet
Actions
Dallah Healthcare Company announces the Board of Directors’ decision to distribute interim cash dividends to shareholders for the fourth quarter of 2025.
| Element List | Explanation |
|---|---|
| Introduction | - |
| Date of the board’s decision | 2026-03-04 Corresponding to 1447-09-15 |
| The Total amount distributed | 50,551,474.00 SAR |
| Number of Shares Eligible for Dividends | 101,102,948 |
| Dividend per share | 0.50 SAR |
| Percentage of Dividend to the Share Par Value (%) | 5 |
| Eligibility date | 2026-03-24 Corresponding to 1447-10-05 |
| Distribution Date | 2026-04-07 Corresponding to 1447-10-19 |
| The name of other official authorities and the details of their non-refusal to the recommendation or decision | N/A |
| Additional Information | The total number of treasury shares not eligible for dividends is 471,821 shares as of this date. The eligibility of dividends shall be for shareholders who hold shares at the close of trading on Tuesday 05/10/1447H corresponding to 24/03/2026G and who are enlisted in the company’s shareholders register with the Securities Depository Center Company at the end of the second trading day following the eligibility date. The company would like to draw the attention of non-resident investors in Saudi Arabia to the fact that cash distributions are subject to a 5% withholding tax, in accordance with the provisions of the Income Tax Law and its Executive Regulation. Accordingly, the company urges non-resident investors in Saudi Arabia who hold tax exemptions on dividend distributions issued by the Zakat, Tax and Customs Authority, to contact the Investor Relations department to provide the supporting documents for tax exemption. For inquiries, please contact the Investor Relations department at: Phone: + 966 (11) 2995769 Email: IR@dallahhealth.com |
The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.
Share
Company Performance
Key Parameters
Last Price 134.7
Net Change -1.4 (-1.03%)
Value Traded (Sar) 5,904,916.7
Volume Traded 44,084
LoginPortletPopupv2
Actions
AddtoWatchlistv2
Actions